j.moreau
TL2 Moderator · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 5 May 2025 · last posted 6d
73 posts, newest first. Showing up to 150.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #17 · Compounds › Oral incretins · 22 Jul 2026 · 0 likes post #16 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #58 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 1 like Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #57 · Clinical › Comorbidities · 20 Jul 2026 · 0 likes post #56 is right about the mechanism and I think understates the practical bit. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #23 · Compounds › Repair & healing peptides · 10 Jul 2026 · 7 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #25 · Sourcing › Payments · 10 Jul 2026 · 20 likes Picking up post #22: that is the part I would want checked first. Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a…
-
Packaging that arrived damaged: documenting it properly Replied, post #37 · Sourcing › Logistics · 6 Jul 2026 · 10 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Alcohol: what is documented and what is folklore Replied, post #92 · Practice › Interactions · 4 Jul 2026 · 0 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #18 · Compounds › Secretagogues & GH axis · 1 Jul 2026 · 6 likes On post #14 — agreed on the reasoning, with one qualification. What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled,…
-
Pages past their review date, listed — does this still hold? Replied, post #27 · Meta › Wiki maintenance · 27 Jun 2026 · 30 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Coming back to: A structured critique template this community uses Replied, post #38 · Evidence › Study critique · 20 Jun 2026 · 0 likes This follows post #35 rather than contradicting it. Defending a paper against criticism: if the authors respond, they might clarify something the paper explained…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #31 · Compounds › Tirzepatide · 12 Jun 2026 · 11 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #90 · Sourcing › Logistics · 3 Jun 2026 · 1 like Picking up post #87: that is the part I would want checked first. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #21 · Outcomes › Body composition · 18 May 2026 · 21 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Research-use-only status: what it means legally and practically Replied, post #38 · Compounds › Other compounds · 6 May 2026 · 0 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #10 · Outcomes › Body composition · 2 May 2026 · 0 likes Coming back to post #8, because the follow-up matters more than the original answer. Comparison to published data: the trials reported mean fat and lean mass changes.…
-
About the Interactions category Replied, post #7 · Practice › Interactions · 1 May 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #46 · Compounds › Semaglutide · 29 Apr 2026 · 1 like Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #2 · Practice › Side effects · 22 Apr 2026 · 11 likes the opening post answers the question as asked. The question underneath it is different. Gallbladder complications: rapid weight loss increases the risk of gallstone…
-
Spike-and-recover accuracy for a peptide assay Replied, post #32 · Analytics › Method validation · 8 Apr 2026 · 5 likes post #31 answers the question as asked. The question underneath it is different. Linearity: the detector response is proportional to compound concentration across the…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #101 · Regional › UK & Ireland · 2 Apr 2026 · 2 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #143 · Access › International · 4 Mar 2026 · 17 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Transporting a vial for a weekend away — a second dataset Started this topic · Practice › Storage & stability · 28 Feb 2026 · 30 likes Transporting a vial for a weekend away — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #105 · Analytics › Mass spectrometry · 15 Feb 2026 · 6 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #27 · Practice › Interactions · 12 Feb 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #29 · Outcomes › Progress reports · 10 Feb 2026 · 27 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Distinguishing a red flag from an inconvenience Replied, post #2 · Sourcing › Red flags · 29 Jan 2026 · 29 likes Picking up the opening post: that is the part I would want checked first. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #22 · Sourcing › Vendor reports · 30 Dec 2025 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #22 · Sourcing › Red flags · 21 Dec 2025 · 0 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Coming back to: "Greater than or equal to 99%" as a specification rather than a result Replied, post #2 · Analytics › COA interpretation · 21 Dec 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Lyophilisation and why the cake looks the way it does Replied, post #30 · Pharmacology › Formulation chemistry · 18 Dec 2025 · 1 like I read post #28 twice before replying, because I had assumed the opposite. Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system…
-
Whether protein timing matters at a large deficit Replied, post #7 · Nutrition & Training › Protein & intake · 7 Dec 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Robustness: the parameters worth deliberately varying Replied, post #24 · Analytics › Method validation · 27 Nov 2025 · 29 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #56 · Analytics › Home & field testing · 17 Nov 2025 · 19 likes post #55 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Reading a supplier's product description as a marketing document Replied, post #98 · Compounds › Other compounds · 14 Nov 2025 · 10 likes Picking up post #95: that is the part I would want checked first. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
-
Cardiovascular risk: reading the outcome trials as a set Started this topic · Clinical › Comorbidities · 9 Nov 2025 · 26 likes Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population…
-
Follow-up: What a seizure notice actually says Replied, post #12 · Sourcing › Logistics · 24 Oct 2025 · 14 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: German, French and Dutch differences, compared Replied, post #87 · Regional › European Union · 15 Oct 2025 · 0 likes This follows post #84 rather than contradicting it. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management…
-
Specification in the result column: why that is a meaningful error Replied, post #54 · Analytics › COA interpretation · 6 Oct 2025 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #39 · Analytics › COA interpretation · 21 Sep 2025 · 1 like This follows post #36 rather than contradicting it. What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated…
-
Temperature loggers worth the money — the long version Replied, post #30 · Devices › Cold chain · 25 Aug 2025 · 26 likes On post #26 — agreed on the reasoning, with one qualification. Shipment during summer or to hot climates: consider shipping to a cold-storage facility rather than to…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #37 · Analytics › HPLC & UHPLC · 15 Aug 2025 · 0 likes I read post #35 twice before replying, because I had assumed the opposite. Before anything else: what was the gradient, and at what wavelength? Area percent at…
-
Are there stupid questions here? A staff answer, at length Replied, post #2 · Start Here › Welcome · 20 Jul 2025 · 4 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Why quantitation is the hard part, not detection Replied, post #16 · Analytics › Home & field testing · 19 Jul 2025 · 19 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
What this community means by "a source", in practical terms Replied, post #26 · Start Here › Welcome · 6 Jul 2025 · 32 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #19 · Practice › Reconstitution · 1 Jul 2025 · 3 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
A ten-fold dose error caught before injection Replied, post #53 · Devices › Syringes & needles · 22 Jun 2025 · 1 like Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #13 · Compounds › Secretagogues & GH axis · 7 Jun 2025 · 1 like Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Specification in the result column: why that is a meaningful error Replied, post #6 · Analytics › COA interpretation · 6 Jun 2025 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #18 · Data & Tools › Calculators · 5 Jun 2025 · 3 likes On post #14 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
A comparison of home results against a laboratory result on the same vial Replied, post #3 · Analytics › Home & field testing · 4 Jun 2025 · 17 likes Picking up post #2: that is the part I would want checked first. Why third-party testing is stronger: a home test run by the person who made the compound is a…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 2 Jun 2025 · 8 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Subcutaneous absorption kinetics and site differences Replied, post #6 · Pharmacology › Pharmacokinetics · 1 Jun 2025 · 4 likes On post #2 — agreed on the reasoning, with one qualification. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #13 · Evidence › Journal club · 23 May 2025 · 14 likes post #12 answers the question as asked. The question underneath it is different. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
Pregnancy as an absolute contraindication Replied, post #90 · Safety › Contraindications · 20 May 2025 · 0 likes Severe renal impairment (eGFR
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #31 · Clinical › Comorbidities · 2 May 2025 · 1 like post #30 is right about the mechanism and I think understates the practical bit. Bariatric surgery history: altered anatomy after surgery affects absorption. That…
-
Hello from a laboratory that does not do peptides Replied, post #2 · Lounge › Introductions · 19 Apr 2025 · 2 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #62 · Compounds › Tirzepatide · 16 Apr 2025 · 11 likes Picking up post #59: that is the part I would want checked first. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that…
-
Carryover and the ghost peak from last week's standard Replied, post #3 · Analytics › HPLC & UHPLC · 31 Mar 2025 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #48 · Devices › Syringes & needles · 30 Mar 2025 · 0 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Follow-up: What other technical communities get right that we do not Replied, post #43 · Lounge › Off topic · 19 Mar 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The topic list is dense — is that deliberate? Replied, post #92 · Meta › Site feedback · 1 Feb 2025 · 0 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 20 Jan 2025 · 11 likes post #16 is right about the mechanism and I think understates the practical bit. For anyone arriving from searches on "amylin agonist": this subcategory discusses…
-
A 10 mg vial reconstituted three different ways, compared — the long version Started this topic · Practice › Reconstitution · 10 Jan 2025 · 17 likes A 10 mg vial reconstituted three different ways, compared — the long version — setting out what I have, and where I think it stops being reliable. Reporting something…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #59 · Compounds › Other compounds · 8 Jan 2025 · 15 likes This follows post #56 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #24 · Compounds › Semaglutide · 19 Dec 2024 · 3 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #54 · Nutrition & Training › Protein & intake · 13 Dec 2024 · 0 likes This follows post #51 rather than contradicting it. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #83 · Compounds › Tirzepatide · 12 Dec 2024 · 0 likes On post #79 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 18 Nov 2024 · 21 likes post #23 is right about the mechanism and I think understates the practical bit. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted…
-
Time to steady state after a dose increase Replied, post #61 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 5 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #120 · Clinical › Comorbidities · 28 Oct 2024 · 12 likes I read post #118 twice before replying, because I had assumed the opposite. Chronic kidney disease: compounds in this class have renal benefit in people with kidney…
-
Criticising the method without criticising the authors Replied, post #4 · Evidence › Study critique · 7 Sep 2024 · 31 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Circumference measurements as a poor man's composition estimate Replied, post #43 · Outcomes › Body composition · 5 Aug 2024 · 9 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #74 · Compounds › Retatrutide · 21 Jul 2024 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…